An exclusive distribution agreement in Brazil powered a Canadian marijuana stock Friday. Here’s some small stocks making big moves on Friday, May 1, 2020 (as of 4 pm EST):
Khiron Life Sciences Corp. (TSXV:KHRN), a Canadian marijuana stock with operations in Latin America, jumped 15% to $0.70 on Friday after announcing an exclusive agreement with Medlive, a pharmaceutical and health products distributor with network of over 3,000 clinics and hospitals in southern Brazil, in which Khiron’s medical cannabis products will be marketed through Medlive’s network of doctor offices, clinics, hospitals and governmental institutions.
As well, shares of StageZero Life Sciences, Ltd. (TSX:SZLS) gained 4% to $0.13 as the Canadian biotechnology company provided an update on its COVID-19 testing in the United States, saying initial interest received is for in excess of 250,000 tests.
Great Thunder Gold Corp. (TSXV:GTG), meanwhile, reported that the Company has started its Phase 1 Exploration Program in Quebec’s Fenelon Gold Camp. GTG’s projects are surrounding and adjacent to Wallbridge Mining’s Fenelon Deposit project and within 6.5km of Balmoral Resources’ Reaper Gold discovery. Great Thunder Gold stock moved up 17% to $0.44 following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Khiron Life Sciences Corp. (TSXV:KHRN), a Canadian marijuana stock with operations in Latin America, jumped 15% to $0.70 on Friday after announcing an exclusive agreement with Medlive, a pharmaceutical and health products distributor with network of over 3,000 clinics and hospitals in southern Brazil, in which Khiron’s medical cannabis products will be marketed through Medlive’s network of doctor offices, clinics, hospitals and governmental institutions.
, on Friday.){kind=link}